From: Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria
Antimicrobial | Community acquired | Healthcare associated | Hospital acquired | Total | P value | ||||
---|---|---|---|---|---|---|---|---|---|
 | Bacteria | n(%) Resistant | Bacteria | n(%) Resistant | Bacteria | n(%) Resistant | Bacteria | n(%) Resistant | |
TMP-SMZ* | 51 | 32 (69) | 111 | 75 (68) | 57 | 45 (79) | 219 | 152 (69) | 0.2 |
Ciprofloxacin | 52 | 48 (92) | 111 | 109 (98) | 57 | 53 (92) | 220 | 210 (95) | 0.1 |
Nitrofurantoin | 50 | 3 (6) | 85 | 7 (8) | 43 | 1 (2) | 178 | 11 (6) | 0.5 |